Invention Grant
US08378102B2 Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
失效
肟和羟胺取代的噻唑并[4,5-c]环化合物和方法
![Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods](/docs/US/2013-02-19/US08378102B2/abs.jpg.600x600.jpg)
- Patent Title: Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
- Patent Title (中): 肟和羟胺取代的噻唑并[4,5-c]环化合物和方法
-
Application No.: US11884060Application Date: 2006-02-08
-
Publication No.: US08378102B2Publication Date: 2013-02-19
- Inventor: Gregory D. Lundquist, Jr. , Tushar A. Kshirsagar , Philip D. Heppner
- Applicant: Gregory D. Lundquist, Jr. , Tushar A. Kshirsagar , Philip D. Heppner
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- International Application: PCT/US2006/004159 WO 20060208
- International Announcement: WO2007/120121 WO 20071025
- Main IPC: C07D513/14
- IPC: C07D513/14 ; A61K31/4365
![Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods](/abs-image/US/2013/02/19/US08378102B2/abs.jpg.150x150.jpg)
Abstract:
Thiazolo[4,5-c]ring compounds, (e.g. thiazolopyridine, thiazoloquinoline, 6,7,8,9-tetrahydrothiazoloquinoline, thiazolonaphthyridine, and 6,7,8,9-tetrahydrothiazolonaphthyridine compounds) having an oxime or hydroxylamine substituent at the 2-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Public/Granted literature
- US20100240693A1 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods Public/Granted day:2010-09-23
Information query
